Drug Discovery and Development Targeting Dementia

Abstract

Dementia, most often associated with neurodegenerative diseases, affects millions of people worldwide, predominantly the elderly. Unfortunately, no treatment is still available. Therefore, there is an urgent need to address this situation. This review presents the state of the art of drug discovery and developments in targeting dementia. Several approaches are discussed, such as drug repurposing, the use of small molecules, and phosphodiesterase inhibitors. Furthermore, the review also provides insights into clinical trials of these molecules. Emphasis has been placed on small molecules and multi-target-directed ligands, as well as disease-modifying therapies. Finally, attention is drawn to the possibilities of applications of nanotechnology in managing dementia.

Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review

“…These experiments showed that the progress of neuronal destruction processes slowed down [ 201 ]. Moreover, the activity of the β-secretase enzyme, which is mainly responsible for the formation of β-amyloid deposits, was reduced, which is a key and important achievement in the therapy of patients suffering from Alzheimer’s disease [ 202 ]. Scientists are also trying to determine the clinical usefulness of TNF-α synthesis inhibitors, which include, inter alia, imide immunomodulatory drugs, including thalidomide [ 6 ].…”

Review on anti-alzheimer drug development: approaches, challenges and perspectives

“…96 It is now under another clinical trial study designed to further evaluate its effect on AD improvement. 97…”

Alzheimer’s Disease: A Molecular Model and Implied Path to Improved Therapy

“…Therapies for AD are usually designed to promote the removal or destruction of amyloid proteins (Aβ protein in the case of AD) or their cleavage products, based on the hypothesis that the observed amyloid causes disease (amyloid cascade hypothesis [ 6 , 7 , 8 ]). However, these therapies have failed to significantly reverse the course of AD [ 7 , 8 , 9 , 10 , 11 , 12 , 13 ].…”